Skip to main content

Written question asked by Mary Glindon (Labour) on Tuesday, 17 July 2012, in the House of Commons. It was due for an answer on Monday, 3 September 2012. It was answered by Paul Burstow (Liberal Democrat) on Monday, 3 September 2012 on behalf of the Department of Health.


Breast Cancer

Question

(2) how many and what proportion of breast cancer patients are offered (a) a written follow-up care plan, (b) a named individual to contact and (c) other personalised information and support in each year for which figures are available;

[118454]

Mrs Glindon:

Answer

Information concerning the number of women with secondary breast cancer who are given access to a clinical nurse specialist (CNS) and the number and proportion of breast cancer patients who are offered a written follow-up care plan, a named individual to contact and other personalised information and support is not collected.

However, ‘The National Report of the 2010 Cancer Patient Experience Survey’, published in December 2010, included a series of questions about CNSs, written information and provision of support. The views of over 67,000 cancer patients were included in the survey results, of which 14,264 had breast cancer. Patients with secondary breast cancer are included in this figure, but are not identified.

Set out in the following table are the responses of patients with breast cancer to questions concerning CNSs, written information and support, presented alongside the results for all cancers.

Questions
Breast cancer (%)
All cancer (%)
Given the name of a CNS
93
84
Given clear written information given about what to do or not do after leaving hospital (in-patient care)
89
82
Given the right amount of information about condition and treatment
89
88
Hospital staff provided information about support and self-help groups
86
79
Definitely given enough emotional support while being treated as an out-patient
69
71

Datasets for the 2010 National Cancer Patient Experience Survey and the forthcoming 2010-11 survey are based on International Classification of Diseases, 10th Revision (ICD-10) codes. C50 covers all malignant neoplasms of the breast, so patients with secondary or recurrent breast cancer cannot be identified separately.

The National Cancer Survivorship Initiative pilot Patient Reported Outcomes Measures survey of cancer survivors in 2011 asked breast cancer patients how' their cancer responded to treatment. One of the possible responses to this question was ‘My breast cancer has come back after it was originally treated’, so these women will be separately identifiable. Results of the pilot are expected to be published in the autumn.

We know that cancer patients greatly value the care and support of CNSs. To support the national health service to develop the CNS work force, ‘Improving Outcomes: A Strategy for Cancer’ sets out our

intention to build the evidence base for the benefits and costs savings that CNSs can offer. This follows an independent report we published in December 2010 that showed that, in many scenarios, the costs of additional support roles are likely to be outweighed by the savings that can be achieved.


Secondary information

Type
Written question
Reference
118454; 549 cc237-8W
Session
2012-13
Subjects
Breast cancer Health services
Contains statistics
Yes
Link
View this Written question on www.publications.parliament.uk